Advice
Following a full submission
1 mg estradiol/2 mg drospirenone (Angeliq) is not recommended for use within NHS Scotland as hormone replacement therapy for oestrogen deficiency symptoms in postmenopausal women more than 1 year post-menopause.
It is effective in reducing the frequency of hot flushes and other symptoms of the menopause but comparative data versus other low dose continuous combined treatment are lacking. The cost-effectiveness has not been demonstrated and there are cheaper alternatives.
Download detailed advice49KB (PDF)
Medicine details
- Medicine name:
- Estradiol 1mg and drospirenone 2mg (Angeliq®)
- SMC ID:
- 230/05
- Indication:
- Hormone replacement therapy
- Pharmaceutical company
- Schering Health Care Ltd
- BNF chapter
- Endocrine system
- Submission type
- Full
- Date advice published
- 09 January 2006